Sarah L. Grinde serves as Executive at ROCHESTER MEDICAL CORPORATION, where they oversee executive responsibilities. Since joining the company, Sarah L. Grinde has executed 4 insider transactions totaling $5.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 14, 2013 involved selling 21,699 shares valued at $434.0K.
Sarah L. Grinde currently holds 21,699 shares of ROCHESTER MEDICAL CORPORATION (ROCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah L. Grinde has been a net buyer of ROCM stock. They have purchased $5.0K and sold $0 worth of shares.
Sarah L. Grinde's most recent insider trade was on Nov 14, 2013, when they sold 21,699 shares at $20.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 25, 2013 | ROCM | $0 | Award | 10,000 | $N/A | Discretionary |
| Dec 12, 2012 | ROCM | $5.0K | Purchase | 500 | $9.90 | Discretionary |